Statistics for Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
Total visits
| views | |
|---|---|
| Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod | 0 |
Total visits per month
| views | |
|---|---|
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
File Visits
| views | |
|---|---|
| Clinical implications for substandard, nonproprietary medicines in multiple sclerosis Focus on fingolimod.pdf | 6 |